Skip to main content
. 2022 Jun 23;8(2):80–85. doi: 10.1016/j.afos.2022.06.001

Table 1.

Baseline clinical, anthropometric and biochemical parameters in study subjects with and without sarcopenia.

Characteristics With sarcopenia (n = 34), mean (SD) Without sarcopenia (n = 83), mean (SD) P-value
Age, yr 55.7 (11.8) 49.9 (15.3) 0.096
Sex 27 males: 7 females 61 males: 22 females 0.184
Duration of CKD, months 18.8 (15.9) 24.0 (20.4) 0.101
Serum creatinine, mg/dL) 3.16 (1.42) 3.43 (1.44) 0.79
Estimated GFR, (mL/min/1.73m2) 26.56 (13.12) 24.13 (11.86) 0.322
CKD stage 3a 3 7 0.638
 3b 10 14
 4 13 45
 5 8 16
Underlying diabetes, % 10 (29.4%) 29 (35.3%) 0.642
Hypertension, % 29 (85.2%) 68 (82.9%) 0.863
Weight, kg 55.1 (8.45) 65.1 (13.3) 0.017
Height, m 1.57 (0.08) 1.59 (0.08) 0.927
Body mass index, kg/m2 22.5 (3.8) 25.7 (5.19) 0.268
Mid upper arm circumference, cm 24.2 (2.6) 26.8 (4.3) 0.032
Skin fold thickness, mm 17.4 (6.2) 20.1 (9.2) 0.113
Hemoglobin, g/dl 10.5 (1.92) 10.7 (2.03) 0.746
Serum albumin, g/dl 3.89 (0.57) 3.96 (0.57) 0.525

CKD, chronic kidney disease; GFR, glomerular filtration rate.